IP Library Granted Patent US 8,119,786
Granted Patent B2
US 8,119,786 · App. 12/559,062 · Granted Feb 21, 2012

Nucleic acids encoding CCL27

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,786
App. No.
12/559,062
Granted
Feb 21, 2012
Kind
B2
Abstract

Novel CC chemokines from human, reagents related thereto including purified proteins, specific antibodies and nucleic acids encoding these chemokines are provided. Also provided are methods of making and using said reagents and diagnostic kits.

Claims (11)

1. An isolated nucleic acid which hybridizes under wash conditions of 0.2 molar salt at pH 7 and a temperature of at least 50° C. to the complement of a nucleic acid comprising the nucleotide sequence set forth in SEQ ID NO: 5; wherein the nucleic acid encodes a polypeptide that chemoattracts CD4+, CLA+ memory T cells.

2. An isolated nucleic acid which comprises the nucleotide sequence set forth in SEQ ID NO: 5.

3. An isolated vector comprising the nucleic acid of claim 1 .

4. An isolated host cell comprising the nucleic acid of claim 1 .

5. An isolated host cell comprising the vector of claim 3 .

6. The host cell of claim 4 which is a prokaryotic cell.

7. The host cell of claim 4 which is a eukaryotic cell.

8. The host cell of claim 6 which is E. Coli.

9. The host cell of claim 7 which is a yeast cell.

10. The host cell of claim 9 which is Pichia or S. cerevisiae.

11. The host cell of claim 7 which is a mammalian cell.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →